CLVRX Mutual Fund

CLVRX Mutual Fund

NAV$43.23
See how much of CLVRX you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
0.19%
Dividend Yield (Current)
7.53%
Holdings
548
Inception Date
Feb 1, 2022
Fund Family
Calvert
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+23.03%
1 Year+35.25%
3 Year+19.32%
5 Year+11.12%
10 Year+12.21%

Asset Allocation

Stocks: 99.83%
Cash: 0.17%
See how much of CLVRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
JPMJpmorgan Chase3.46%
BAC.KBank Of America Corp2.02%
MRKMerck & Company Inc1.74%
WFCWells Fargo & Co.1.47%
UNHUnitedhealth Group, Inc.1.46%
Top 10 Concentration: 16.66%Report Date: Mar 31, 2026
Download all 548 holdings for CLVRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
7.53%
Frequency
Annually

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

CLVRX Mutual Fund Overview

CLVRX Mutual Fund (Calvert US Large Cap Value Responsible Index Fund Class R6) is managed by Calvert. CLVRX expense ratio is 0.19%, holding 548 positions across sectors including Financials, Health Care, Industrials. Inception date: 2022-02-01.

CLVRX performance shows a YTD return of 23.03%. The 1-year return is 35.25% and the 5-year return is 11.12%. CLVRX dividend yield stands at 7.53%, paid annually.

CLVRX top holdings include Jpmorgan Chase (3.5%), Bank Of America Corp (2.0%), Merck & Company Inc (1.7%), Wells Fargo & Co. (1.5%), Unitedhealth Group, Inc. (1.5%). Go to all CLVRX holdings, CLVRX sectors, or CLVRX dividends.

CLVRX can be compared against other funds. Use CLVRX overlap to find shared positions, or CLVRX vs another fund for a side-by-side view. CLVRX alternatives are available via the screener, along with tax-loss harvesting opportunities.